Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
766.48-
QQQ
728.331.06%
BTC/USD
84522.464.1435%
DIA
519.100.62%
GLD
399.030.53%
TLT
81.690.54%

Caris Life Sciences Inc (CAI) Stock Price, Quote, News & History

CAINASDAQ
Trade with Public
Trade with Public
$29.98
-0.94-3.04%
At close: Sep 17, 5:00 PM EST
$29.83
-1.09-3.53%
Pre-Market: 5:09 AM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipDividendsCompareOptionsStock Report

Caris Life Sciences (CAI) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
-
Close
$29.98
Volume / Avg.
2.48K / 4.72M
Day Range
- - -
52 Wk Range
14.19 - 34.54
Market Cap
$8.43B
P/E Ratio
3.13
Dividend Yield
-
Exchange
NASDAQ
RSI
71
Short Interest
11.88%
Days to Cover
2.45

Recent Caris Life Sciences, Inc. News

10-Year Yield Tops 5%, Oil Storms Past $105: Stock Market Today

The 10-year Treasury yield broke 5% for the first time since 2007 as WTI surged past $105 on Saudi pipeline outages, pressuring stocks ahead of the Fed.
Piero Cingari

Nasdaq 100 Falls as Hot PCE Inflation Stirs Rate-Hike Bets: Stock Market Today

Nasdaq 100 falls 0.6% as traders wait on Nvidia and hot July PCE revives September rate-hike bets. Energy leads, gold sinks 1.3% to $4,599.
Piero Cingari

Bessent's Bond Rescue Fizzles, Walmart Craters 9%: Stock Market Today

Long-end Treasury yields snapped back toward 20-month highs; Walmart posted its worst session in four years.
Piero Cingari

Deere, Coinbase Global, Nordson And Other Big Stocks Moving Higher On Wednesday

Dow Jones down 300 points, Deere & Co shares up 7.9% after beating earnings expectations. SCTX, SCSC, BTBT, MRVI, HIVE, AHG, TEM, MARA, LB also gain.
Avi Kapoor

Stock Market Today: Nasdaq 100 Slips As Broadcom Plunges, Bitcoin Hits 4-Month Lows

A selloff in high-flying chipmakers split Wall Street on Thursday, with Broadcom Inc. (NASDAQ:AVGO)‘s disappointing AI-revenue forecast testing the artificial-intelli
Piero Cingari

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
168.56M
Investing Cash Flow (TTM)
-144.72M
Financing Cash Flow (TTM)
-53.78M
Free Cash Flow (TTM)
123.96M
Capital Expenditure (TTM)
-44.60M
Net Change in Cash (TTM)
-29.94M

Analyst Trends and Forecast

0
0
0
0
Jun
2
Jul
2
Aug
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$8.13B
PE Ratio (TTM)
3.13
PE Ratio (FWD)
41.15
PEG Ratio (TTM)
-
PS Ratio (TTM)
8.59
PB Ratio (TTM)
14.32
Earnings Yield % (TTM)
31.95%
Earnings Yield % (FWD)
2.43%
EV / EBITDA (TTM)
47.09
Price / EBITDA (TTM)
49.20
Price / Free Cash Flow (TTM)
68.54
Book Value / Share
$2.09

Company Debt

Total Debt
$393.15M
LT Debt
$392.97M
LT Debt Issuance (TTM)
$393.50M
LT Debt Repayment (TTM)
-$406.45M
Total Cash
$690.92M
Debt to Equity
0.76
Issuance of Debt (TTM)
-$12.95M
Repayment of Debt (TTM)
-$406.45M

Key Statistics

Open
-
Close
$29.98
Volume / Avg.
2.48K / 4.72M
Day Range
- - -
52 Wk Range
14.19 - 34.54
Market Cap
$8.43B
P/E Ratio
3.13
Dividend Yield
-
Exchange
NASDAQ
RSI
71
Short Interest
11.88%
Days to Cover
2.45

About

Sector
Health Care
Industry
Biotechnology
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algor...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Caris Life Sciences (CAI) stock?

A

You can purchase shares of Caris Life Sciences (NASDAQ:CAI) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Caris Life Sciences (CAI) competitors?

Q

What is the forecast, or price target, for Caris Life Sciences (CAI) stock?

A

Caris Life Sciences has a consensus price target of $28.85.

Q

What is the current price for Caris Life Sciences (CAI)?

A

The stock price for Caris Life Sciences (NASDAQ: CAI) is $29.83 last updated September 21, 2026 at 2:04 AM EDT.

Q

Does Caris Life Sciences (CAI) pay a dividend?

A

There are no upcoming dividends for Caris Life Sciences.

Q

When is Caris Life Sciences (NASDAQ:CAI) reporting earnings?

A

Caris Life Sciences does not have any upcoming earnings scheduled.

Q

Is Caris Life Sciences (CAI) going to split?

A

There is no upcoming split for Caris Life Sciences.

Q

What sector and industry does Caris Life Sciences (CAI) operate in?

A

Caris Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved